Viking Therapeutics (VKTX) Return on Equity (2016 - 2025)
Historic Return on Equity for Viking Therapeutics (VKTX) over the last 11 years, with Q4 2025 value amounting to 0.53%.
- Viking Therapeutics' Return on Equity fell 4100.0% to 0.53% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.53%, marking a year-over-year decrease of 4100.0%. This contributed to the annual value of 0.47% for FY2025, which is 2900.0% down from last year.
- As of Q4 2025, Viking Therapeutics' Return on Equity stood at 0.53%, which was down 4100.0% from 0.31% recorded in Q3 2025.
- In the past 5 years, Viking Therapeutics' Return on Equity ranged from a high of 0.1% in Q2 2024 and a low of 0.53% during Q4 2025
- Its 5-year average for Return on Equity is 0.27%, with a median of 0.24% in 2023.
- Its Return on Equity has fluctuated over the past 5 years, first soared by 3700bps in 2024, then tumbled by -4100bps in 2025.
- Quarter analysis of 5 years shows Viking Therapeutics' Return on Equity stood at 0.26% in 2021, then tumbled by -75bps to 0.46% in 2022, then skyrocketed by 48bps to 0.24% in 2023, then soared by 49bps to 0.12% in 2024, then plummeted by -333bps to 0.53% in 2025.
- Its Return on Equity stands at 0.53% for Q4 2025, versus 0.31% for Q3 2025 and 0.21% for Q2 2025.